{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:52:24Z","timestamp":1788997944081,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.alit.2022.05.010","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T04:52:56Z","timestamp":1655441576000},"page":"490-497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Efficacy of a house dust mite sublingual immunotherapy tablet as add-on dupilumab in asthma with rhinitis"],"prefix":"10.1016","volume":"71","author":[{"given":"Makoto","family":"Hoshino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Akitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Ohtawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl","key":"10.1016\/j.alit.2022.05.010_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","article-title":"Allergen immunotherapy: a practice parameter third update","volume":"127","author":"Cox","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2022.05.010_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jaci.2015.12.1300","article-title":"International consensus on allergen immunotherapy II: Mechanisms, standardization, and pharmacoeconomics","volume":"137","author":"Jutel","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2022.05.010_bib3","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.rmed.2014.07.017","article-title":"SQ HDM SLIT-tablet (ALK) in treatment of asthma-post hoc results from a randomised trial","volume":"108","author":"de Blay","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.alit.2022.05.010_bib4","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jaci.2014.03.019","article-title":"Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial","volume":"134","author":"Mosbech","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2022.05.010_bib5","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1001\/jama.2016.3964","article-title":"Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma","volume":"315","author":"Virchow","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.alit.2022.05.010_bib6","series-title":"Global Strategy for Asthma Management and Prevention. Updated","year":"2017"},{"key":"10.1016\/j.alit.2022.05.010_bib7","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/all.13749","article-title":"EAACI Guidelines on Allergen Immunotherapy: house dust mite-driven allergic asthma","volume":"74","author":"Agache","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2022.05.010_bib8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2022.05.010_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd4624","article-title":"Targeting key proximal drivers of type 2 inflammation in disease","volume":"15","author":"Gandhi","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.alit.2022.05.010_bib10","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1073\/pnas.1323896111","article-title":"Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes","volume":"111","author":"Macdonald","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.alit.2022.05.010_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/cea.12880","article-title":"Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications","volume":"47","author":"Robinson","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2022.05.010_bib12","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","article-title":"Dupilumab in persistent asthma with elevated eosinophil levels","volume":"368","author":"Wenzel","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2022.05.010_bib13","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","article-title":"Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma","volume":"378","author":"Rabe","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2022.05.010_bib14","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2022.05.010_bib15","series-title":"[Guideline of Respiratory Function Tests -- Spirometry, Flow-Volume Curve, Diffusion Capacity of the Lung]","year":"2004"},{"key":"10.1016\/j.alit.2022.05.010_bib16","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.rmed.2009.12.005","article-title":"Correlation between airflow limitation and airway dimensions assessed by multidetector CT in asthma","volume":"104","author":"Hoshino","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.alit.2022.05.010_bib17","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1440-1843.2012.02130.x","article-title":"Effects of budesonide\/formoterol combination versus budesonide on airway dimensions in asthma","volume":"7","author":"Hoshino","year":"2012","journal-title":"Respirology"},{"key":"10.1016\/j.alit.2022.05.010_bib18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.rmed.2004.10.008","article-title":"Measurement properties and interpretation of three shortened versions of the asthma control questionnaire","volume":"99","author":"Juniper","year":"2005","journal-title":"Respir Med"},{"key":"10.1016\/j.alit.2022.05.010_bib19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/thx.47.2.76","article-title":"Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials","volume":"47","author":"Juniper","year":"1992","journal-title":"Thorax"},{"key":"10.1016\/j.alit.2022.05.010_bib20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0091-6749(99)70380-5","article-title":"Validation of the standardized version of the rhinoconjunctivitis quality of life questionnaire","volume":"104","author":"Juniper","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2022.05.010_bib21","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0091-6749(95)70255-5","article-title":"Studies on the relationship between the level of specific IgE antibodies and the clinical expression of allergy: I. Definition of levels distinguishing patients with symptomatic from patients with asymptomatic allergy to common aeroallergens","volume":"96","author":"Pastorello","year":"1995","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2022.05.010_bib22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaci.2013.12.1088","article-title":"Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens","volume":"133","author":"Akdis","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2022.05.010_bib23","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jaci.2017.10.010","article-title":"Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers","volume":"140","author":"Shamji","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2022.05.010_bib24","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/cea.13954","article-title":"Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases","volume":"51","author":"Hamilton","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2022.05.010_bib25","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0091-6749(96)70205-1","article-title":"Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma","volume":"97","author":"Durham","year":"1996","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2022.05.010_bib26","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1398-9995.2005.00832.x","article-title":"Molecular and cellular targets of anti-IgE antibodies","volume":"60","author":"Inf\u00fchr","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2022.05.010_bib27","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.4049\/jimmunol.158.3.1438","article-title":"Down-regulation of Fc(epsilon)RI expression on human basophils during in\u00a0vivo treatment of atopic patients with anti-IgE antibody","volume":"158","author":"MacGlashan","year":"1997","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.alit.2022.05.010_bib28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2222.2008.03121.x","article-title":"Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma","volume":"39","author":"Kopp","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2022.05.010_bib29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jaci.2009.11.022","article-title":"Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma","volume":"125","author":"Massanari","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2022.05.010_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40413-016-0132-1","article-title":"Effect of adjuvanted and standard sublingual immunotherapy on respiratory function in pure rhinitis due to house dust mite over a 5-year period","volume":"10","author":"Marogna","year":"2017","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.alit.2022.05.010_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1081\/COPD-200053377","article-title":"Minimal clinically important differences in COPD lung function","volume":"2","author":"Donohue","year":"2005","journal-title":"COPD"},{"key":"10.1016\/j.alit.2022.05.010_bib32","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","article-title":"Cluster analysis and clinical asthma phenotypes","volume":"178","author":"Haldar","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2022.05.010_bib33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri3786","article-title":"Type 2 inflammation in asthma--present in most, absent in many","volume":"15","author":"Fahy","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.alit.2022.05.010_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12948-017-0064-5","article-title":"Effects of specific allergen immunotherapy on biological markers and clinical parameters in asthmatic children: a controlled-real life study","volume":"15","author":"Djuric-Filipovic","year":"2017","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.alit.2022.05.010_bib35","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jaci.2013.11.012","article-title":"Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis","volume":"133","author":"Bergmann","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2022.05.010_bib36","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jaci.2016.06.044","article-title":"Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial","volume":"138","author":"Nolte","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2022.05.010_bib37","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/all.12188","article-title":"House dust mite sublingual immunotherapy is safe and appears to be effective in moderate, persistent asthma","volume":"69","author":"Wang","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2022.05.010_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/thoraxjnl-2014-205634","article-title":"External validation of blood eosinophils, FENO and serum periostin as surrogates for sputum eosinophils in asthma","volume":"70","author":"Wagener","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.alit.2022.05.010_bib39","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jaci.2014.09.034","article-title":"High blood eosinophil counts predict sputum eosinophilia in patients with severe asthma","volume":"135","author":"Fowler","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2022.05.010_bib40","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S2213-2600(15)00050-8","article-title":"Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis","volume":"3","author":"Korevaar","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.alit.2022.05.010_bib41","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jaci.2013.09.039","article-title":"Quantitative computed tomography-derived clusters: redefining airway remodeling in asthmatic patients","volume":"133","author":"Gupta","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2022.05.010_bib42","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1378\/chest.07-2779","article-title":"Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with pathology","volume":"134","author":"Aysola","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.alit.2022.05.010_bib43","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1164\/ajrccm.162.4.9909044","article-title":"Airway wall thickness in asthma assessed by computed tomography. Relation to clinical indices","volume":"62","author":"Niimi","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2022.05.010_bib44","first-page":"35","article-title":"Serum specific IgE: a biomarker of response to allergen immunotherapy","volume":"24","author":"Ciprandi","year":"2014","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.alit.2022.05.010_bib45","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jaci.2015.05.023","article-title":"Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract","volume":"137","author":"Schmid","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2022.05.010_bib46","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4168\/aair.2018.10.1.18","article-title":"A\u00a0Retrospective study of clinical response predictors in subcutaneous allergen immunotherapy with house dust mites for allergic rhinitis","volume":"10","author":"Lee","year":"2018","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.alit.2022.05.010_bib47","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaci.2009.02.012","article-title":"Evaluation of serum s-IgE\/total IgE ratio in predicting clinical response to allergen-specific immunotherapy","volume":"123","author":"Di Lorenzo","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2022.05.010_bib48","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/all.13749","article-title":"EAACI guidelines on allergen immunotherapy: house dust mite-driven allergic asthma","volume":"74","author":"Agache","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2022.05.010_bib49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40521-018-0176-2","article-title":"Duration of allergen immunotherapy for long-term efficacy in allergic rhinoconjunctivitis","volume":"5","author":"Penagos","year":"2018","journal-title":"Curr Treat Options Allergy"},{"key":"10.1016\/j.alit.2022.05.010_bib50","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jaci.2013.09.004","article-title":"An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies","volume":"132","author":"Calderon","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2022.05.010_bib51","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice","volume":"180","author":"Reddel","year":"2009","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S132389302200051X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S132389302200051X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:11:48Z","timestamp":1761156708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S132389302200051X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S132389302200051X"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2022.05.010","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of a house dust mite sublingual immunotherapy tablet as add-on dupilumab in asthma with rhinitis","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2022.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society of Allergology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}